Company / R&D Expense
Mettler Toledo R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$199.4M
FY2025
5-year range
$140.1M / $199.4M
FY2021-FY2025
Trend
+5.3%
vs FY2024
Sector context
#36 of 110
Health Care
What the data says
At $199M, Mettler Toledo's r&d expense ranks #36 of 110 in the Health Care sector. R&D Expense has increased for 3 consecutive years, from $140M in FY2022 to $199M in FY2025.
Based on SEC 10-K filings.
$199M in FY2025 with a 5-year CAGR of +7.2%.
Improved from $185M to $199M over the past 2 years.
Health Care sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +12.5%
- 5-Year CAGR
- +7.2%
- 10-Year CAGR
- -
Sector benchmark
#36 of 110 in Health CareTop 33% of 110This company $199.4M Sector average $298.2M
▼
-33.1% below sector average
Key checks
Key Insights
- Mettler Toledo's r&d expense has grown for 3 consecutive years.
- 5-year CAGR of +7.2%, indicating consistent growth.
- In FY2025, r&d expense increased 5.3% year-over-year.
- Ranks #36 out of 110 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 3.22 (safe zone, above 2.9 threshold)
- Strong profit margin: 21.2%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $199.4M | +5.3% |
| FY2024 | $189.4M | +2.2% |
| FY2023 | $185.3M | +32.2% |
| FY2022 | $140.1M | -2.7% |
| FY2021 | $143.9M | +2.0% |
| FY2020 | $141.1M | +9.9% |
| FY2019 | $128.3M | -9.0% |
| FY2018 | $141.1M | +9.9% |
| FY2017 | $128.3M | +7.6% |
| FY2016 | $119.2M | +0.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026